| Literature DB >> 5677211 |
Abstract
A field trial is reported in which good sero-conversion rates were obtained when a dose of 200 TCID(50) Beckenham 31 strain (Wellcovax) measles vaccine was administered by Ped-O-Jet subcutaneously in a volume of 0.5 ml. per dose. It is suggested that use of this reduced dosage would lead to a significant reduction in the cost per dose of the vaccine, especially when administered on a scale large enough to justify the use of multidose containers.Entities:
Mesh:
Substances:
Year: 1968 PMID: 5677211 PMCID: PMC1912046 DOI: 10.1136/bmj.4.5622.28
Source DB: PubMed Journal: Br Med J ISSN: 0007-1447